Top compounds associated with response to MVD


Feature Type Standardized
Nominal ANOVA
mRNA lenvatinib CTRPv2 pan-cancer AAC 0.009 0.8
mRNA Bryostatin 1 FIMM pan-cancer AAC -0.036 0.8
mRNA masitinib CTRPv2 pan-cancer AAC -0.0088 0.8
mRNA CIL55A CTRPv2 pan-cancer AAC 0.012 0.8
mRNA Nutlin-3 CTRPv2 pan-cancer AAC 0.0083 0.8
mRNA ABT-199 CTRPv2 pan-cancer AAC -0.01 0.8
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.0067 0.8
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0082 0.8
mRNA Epothilone B GDSC1000 pan-cancer AAC -0.008 0.8
mRNA lenalidomide GDSC1000 pan-cancer AAC -0.0083 0.8
Download CSV